Wanjia Asset Management Co.,Ltd - Hk Connect Innovative Drug ETF (SHA:520700)

Assets	730.99M
Expense Ratio	n/a
PE Ratio	18.74
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-8.20%

Volume	311,623,000
Open	1.705
Previous Close	1.704
Day's Range	1.680 - 1.718
52-Week Low	1.186
52-Week High	1.944
Beta	n/a
Holdings	44
Inception Date	Sep 13, 2024

About 520700

520700.SS was created on 2024-09-13 by Wanjia. The fund's investment portfolio concentrates primarily on health care equity.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 520700
• Provider: Wanjia
• Index Tracked: CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net

Performance

520700 had a total return of -8.20% in the past year, including dividends. Since the fund's inception, the average annual return has been 33.74%.

Top 10 Holdings

70.32% of assets

Name	Symbol	Weight
WuXi Biologics (Cayman) Inc.	2269	10.58%
Innovent Biologics, Inc.	1801	10.09%
BeOne Medicines AG	6160	9.70%
WuXi AppTec Co., Ltd.	2359	8.33%
Akeso, Inc.	9926	7.10%
CSPC Pharmaceutical Group Limited	1093	6.16%
Hansoh Pharmaceutical Group Company Limited	3692	5.90%
Sino Biopharmaceutical Limited	1177	5.42%
3SBio Inc.	1530	3.76%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	6990	3.27%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error